Hemogenyx (HEMO.L): CDX Patent Application | Faron Pharma (FARN.L): Clevegen Phase1/2 study update
12 Jul 2019
SP Angel Healthcare - Morning Comment
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare - Morning Comment
- Published:
12 Jul 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
4
Hemogenyx (HEMO.L): CDX Patent Application | Faron Pharma (FARN.L): Clevegen Phase1/2 study update